190 related articles for article (PubMed ID: 353599)
21. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
Ximenes J; Hirai CK; Takenaka IM
J Int Med Res; 1979; 7(5):375-8. PubMed ID: 115732
[TBL] [Abstract][Full Text] [Related]
22. [New plasmid resistance of Staphylococcus aureus to aminosides (gentamicin, tobramycin, amikacin].
Soussy CJ; Dublanchet A; Cormier M; Bismuth R; Mizon F; Chardon H; Duval J; Fabiani G
Nouv Presse Med; 1976 Nov; 5(39):2599-602. PubMed ID: 995590
[TBL] [Abstract][Full Text] [Related]
23. Amikacin.
Gleckman R
Am Fam Physician; 1976 Dec; 14(6):75. PubMed ID: 998471
[No Abstract] [Full Text] [Related]
24. Clinical and microbiologic consequences of amikacin use during a 42-month period.
Berk SL; Alvarez S; Ortega G; Verghese A; Holtsclaw-Berk SA
Arch Intern Med; 1986 Mar; 146(3):538-41. PubMed ID: 3954526
[TBL] [Abstract][Full Text] [Related]
25. Analysis of neomycin, kanamycin, tobramycin and amikacin resistance mechanisms in gentamicin-resistant isolates of Enterobacteriaceae.
Adwan K; Abu-Hasan N; Al-Asmar H
J Med Microbiol; 1998 Nov; 47(11):1019-21. PubMed ID: 9822302
[TBL] [Abstract][Full Text] [Related]
26. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
27. Cefoxitin: synergism with aminoglycosides in vitro.
Une T; Osada Y; Ogawa H
Arzneimittelforschung; 1981; 31(5):761-4. PubMed ID: 6791664
[TBL] [Abstract][Full Text] [Related]
28. Gentamicin-resistant Serratia marcescens endophthalmitis.
Gammon JA; Schwab I; Joseph P
Arch Ophthalmol; 1980 Jul; 98(7):1221-3. PubMed ID: 6994702
[TBL] [Abstract][Full Text] [Related]
29. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
Murray PR
Antimicrob Agents Chemother; 1980 Mar; 17(3):474-6. PubMed ID: 6252830
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.
Eickhoff TC; Ehret JM
Antimicrob Agents Chemother; 1977 May; 11(5):791-6. PubMed ID: 879733
[TBL] [Abstract][Full Text] [Related]
31. [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
Ronco E; Migueres ML; Vacheron F; Guenounou M
Pathol Biol (Paris); 1988 May; 36(5):430-4. PubMed ID: 3043339
[TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of five aminoglycosides for treatment.
Rosin H; Naumann P; Reintjens E; Köhler M
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
Maes P
J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
[TBL] [Abstract][Full Text] [Related]
34. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
Schassan HH; Witt U
Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
[TBL] [Abstract][Full Text] [Related]
35. Ototoxicity of tobramycin, gentamicin, amikacin and sisomicin in the guinea pig.
Brummett RE; Fox KE; Bendrick TW; Himes DL
J Antimicrob Chemother; 1978 May; 4 Suppl A():73-83. PubMed ID: 659353
[No Abstract] [Full Text] [Related]
36. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Bovelacci A; Montini G; Ramacciotti PG
Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
[TBL] [Abstract][Full Text] [Related]
37. Invitro comparative evaluation of aminoglycosides at a cancer centre.
Biswas SK; Kelkar RS
Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
[TBL] [Abstract][Full Text] [Related]
38. [Studies on the antimicrobial activities of gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa isolated at Hokkaido University Hospital].
Sato K; Matsumiya H; Saito A
Jpn J Antibiot; 1982 May; 35(5):1240-8. PubMed ID: 6813532
[TBL] [Abstract][Full Text] [Related]
39. Potentiation of magnesium sulfate--induced neuromuscular weakness by gentamicin, tobramycin, and amikacin.
L'Hommedieu CS; Nicholas D; Armes DA; Jones P; Nelson T; Pickering LK
J Pediatr; 1983 Apr; 102(4):629-31. PubMed ID: 6834204
[No Abstract] [Full Text] [Related]
40. Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
Ling GV; Conzelman GM; Franti CE; Ruby AL
Am J Vet Res; 1981 Oct; 42(10):1792-4. PubMed ID: 7325444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]